Published in PLoS One on February 06, 2015
Obesity-related known and candidate SNP markers can significantly change affinity of TATA-binding protein for human gene promoters. BMC Genomics (2015) 0.86
A Western-style obesogenic diet alters maternal metabolic physiology with consequences for fetal nutrient acquisition in mice. J Physiol (2017) 0.81
Effect of Octreotide on Hepatic Steatosis in Diet-Induced Obesity in Rats. PLoS One (2016) 0.79
Chronic Trypanosoma cruzi infection potentiates adipose tissue macrophage polarization toward an anti-inflammatory M2 phenotype and contributes to diabetes progression in a diet-induced obesity model. Oncotarget (2016) 0.77
Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology (2005) 29.57
Identification and expression cloning of a leptin receptor, OB-R. Cell (1995) 9.74
Magnetic resonance spectroscopy to measure hepatic triglyceride content: prevalence of hepatic steatosis in the general population. Am J Physiol Endocrinol Metab (2004) 8.36
Hepatic insulin resistance is sufficient to produce dyslipidemia and susceptibility to atherosclerosis. Cell Metab (2008) 7.97
Obesity and nonalcoholic fatty liver disease: biochemical, metabolic, and clinical implications. Hepatology (2010) 5.35
STAT3 signalling is required for leptin regulation of energy balance but not reproduction. Nature (2003) 5.27
SOCS-1 and SOCS-3 block insulin signaling by ubiquitin-mediated degradation of IRS1 and IRS2. J Biol Chem (2002) 4.84
Suppressor of cytokine signaling 1 (SOCS-1) and SOCS-3 cause insulin resistance through inhibition of tyrosine phosphorylation of insulin receptor substrate proteins by discrete mechanisms. Mol Cell Biol (2004) 3.79
Activation of downstream signals by the long form of the leptin receptor. J Biol Chem (2000) 3.52
Two defects contribute to hypothalamic leptin resistance in mice with diet-induced obesity. J Clin Invest (2000) 3.50
FoxO proteins in insulin action and metabolism. Trends Endocrinol Metab (2005) 3.47
Non-alcoholic fatty liver disease: the mist gradually clears. J Hepatol (2008) 3.03
Central role of suppressors of cytokine signaling proteins in hepatic steatosis, insulin resistance, and the metabolic syndrome in the mouse. Proc Natl Acad Sci U S A (2004) 2.54
Role of STAT-3 in regulation of hepatic gluconeogenic genes and carbohydrate metabolism in vivo. Nat Med (2004) 2.51
SOCS3 mediates feedback inhibition of the leptin receptor via Tyr985. J Biol Chem (2000) 2.41
Role of hypothalamic Foxo1 in the regulation of food intake and energy homeostasis. Nat Neurosci (2006) 2.36
Recent advances in understanding leptin signaling and leptin resistance. Am J Physiol Endocrinol Metab (2009) 2.27
Diet-induced obesity alters AMP kinase activity in hypothalamus and skeletal muscle. J Biol Chem (2006) 2.13
Cell type-dependent pro- and anti-inflammatory role of signal transducer and activator of transcription 3 in alcoholic liver injury. Gastroenterology (2008) 1.90
Signal transducer and activator of transcription 3 in liver diseases: a novel therapeutic target. Int J Biol Sci (2011) 1.70
Effects of a novel glycogen synthase kinase-3 inhibitor on insulin-stimulated glucose metabolism in Zucker diabetic fatty (fa/fa) rats. Diabetes (2002) 1.59
Persistent diet-induced obesity in male C57BL/6 mice resulting from temporary obesigenic diets. PLoS One (2009) 1.48
Insulin resistance in nonalcoholic fatty liver disease. Curr Pharm Des (2010) 1.41
Insulin resistance and obesity in childhood. Eur J Endocrinol (2008) 1.40
Specific role for acyl CoA:Diacylglycerol acyltransferase 1 (Dgat1) in hepatic steatosis due to exogenous fatty acids. Hepatology (2009) 1.32
Leptin-induced nuclear translocation of STAT3 immunoreactivity in hypothalamic nuclei involved in body weight regulation. J Neurosci (2001) 1.28
Hypothalamic phosphatidylinositol 3-kinase pathway of leptin signaling is impaired during the development of diet-induced obesity in FVB/N mice. Endocrinology (2007) 1.27
STAT3 targets the regulatory regions of gluconeogenic genes in vivo. Mol Endocrinol (2009) 1.24
Liver triglyceride secretion and lipid oxidative metabolism are rapidly altered by leptin in vivo. Endocrinology (2005) 1.12
Liver-specific suppressor of cytokine signaling-3 deletion in mice enhances hepatic insulin sensitivity and lipogenesis resulting in fatty liver and obesity. Hepatology (2010) 1.10
Effects of metformin, pioglitazone, and silymarin treatment on non-alcoholic Fatty liver disease: a randomized controlled pilot study. Hepat Mon (2012) 1.04
FoxO1 inhibits leptin regulation of pro-opiomelanocortin promoter activity by blocking STAT3 interaction with specificity protein 1. J Biol Chem (2008) 1.04
Resistance to leptin action is the major determinant of hepatic triglyceride accumulation in vivo. FASEB J (2006) 1.02
Leptin, free leptin index, insulin resistance and liver fibrosis in children with non-alcoholic fatty liver disease. Eur J Endocrinol (2006) 1.01
Curcumin inhibits hepatic protein-tyrosine phosphatase 1B and prevents hypertriglyceridemia and hepatic steatosis in fructose-fed rats. Hepatology (2010) 0.97
Regulation of insulin and leptin signaling by muscle suppressor of cytokine signaling 3 (SOCS3). PLoS One (2012) 0.96
Lipid sensing and insulin resistance in the brain. Cell Metab (2012) 0.93
Serum leptin and soluble leptin receptor in non-alcoholic fatty liver disease. World J Gastroenterol (2008) 0.93
Disruption of hepatic leptin signaling protects mice from age- and diet-related glucose intolerance. Diabetes (2010) 0.92
Berberine reducing insulin resistance by up-regulating IRS-2 mRNA expression in nonalcoholic fatty liver disease (NAFLD) rat liver. Eur J Pharmacol (2011) 0.92
A role for hepatic leptin signaling in lipid metabolism via altered very low density lipoprotein composition and liver lipase activity in mice. Hepatology (2012) 0.89
The effect of high-fat diet-induced obesity on cardiovascular toxicity in Wistar albino rats. Hum Exp Toxicol (2010) 0.87
Beneficial effects of rosuvastatin on insulin resistance, adiposity, inflammatory markers and non-alcoholic fatty liver disease in mice fed on a high-fat diet. Clin Sci (Lond) (2012) 0.83
Levels of plasma insulin, leptin and adiponectin, and activities of key enzymes in carbohydrate metabolism in skeletal muscle and liver in fasted ICR mice fed dietary n-3 polyunsaturated fatty acids. J Nutr Biochem (2007) 0.83
Increased soluble leptin receptor levels in morbidly obese patients with insulin resistance and nonalcoholic fatty liver disease. Obesity (Silver Spring) (2010) 0.82
Serum leptin as a predictor of fatty liver in 7-year-old Korean children. Ann Nutr Metab (2008) 0.80
Expression and regulation of facilitative glucose transporters in equine insulin-sensitive tissue: from physiology to pathology. ISRN Vet Sci (2014) 0.79
Increased hepatic insulin sensitivity in mice lacking inhibitory leptin receptor signals. Endocrinology (2011) 0.79
Regulation of leptin release by insulin, glucocorticoids, G(i)-coupled receptor agonists, and pertussis toxin in adipocytes and adipose tissue explants from obese humans in primary culture. Metabolism (2003) 0.76
The efficacy and safety of traditional chinese medicine (jiang zhi granule) for nonalcoholic Fatty liver: a multicenter, randomized, placebo-controlled study. Evid Based Complement Alternat Med (2013) 0.82
[The joint pathway of metabolism and inflammation in nonalcoholic fatty liver disease]. Zhonghua Gan Zang Bing Za Zhi (2011) 0.75
Characterization of a mutant form of human apolipoprotein B (Thr26_Tyr27del) associated with familial hypobetalipoproteinemia. Biochim Biophys Acta (2016) 0.75